Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum-free versus serum-containing conditions

Molecular Therapy

Volumn 5, Issue 3, 2002, Pages 316-322

  Kluge, Kimberley A ^a   Bonifacino, Aylin C ^a   Sellers, Stephanie ^a   Agricola, Brian A ^a   Donahue, Robert E ^a   Dunbar, Cynthia E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL MARKER; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CLINICAL PROTOCOL; COLONY FORMING UNIT GM; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; NONHUMAN; RHESUS MONKEY; SERUM; STEM CELL MOBILIZATION; SUPERNATANT; VIRAL GENE THERAPY; WHOLE BODY RADIATION;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES; TRIXIS; UNIDENTIFIED RETROVIRUS;

EID: 0036200737     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0544     Document Type: Article

References (37)

1. Gene transfer to hematopoietic stem cells: Implications for gene therapy of human disease
2. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
3. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
4. Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor b neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
5. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
6. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
7. The transmissible spongiform encephalopathy agents: Concerns and responses of United States regulatory agencies in maintaining the safety of biologics
8. Serum free culture of purified CD34+ cells yields large expansions of both myeloid and erythroid progenitors
9. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium
10. Murine long-term repopulating ability is compromised by ex vivo culture in serum-free media despite the preservation of committed progenitors
11. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
12. Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions
13. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum free conditions
14. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
15. Prolonged high-level detection of retrovirally-marked hematopoietic cells in non-human primates after transduction of CD34+ progenitors using clinically feasible methods
16. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease
17. Gene transfer into hematopoietic stem cells of nonhuman primates
18. An update on the use of non-human primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells
19. Serum-free production, concentration and purification of recombinant retroviruses
20. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor
21. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons
22. Rapid isolation and serum-free expansion of human CD34+ cells
23. Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures
24. Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media
25. The ex vivo expansion capacity of normal human bone marrow cells is dependent on experimental conditions: Role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures
26. Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines
27. Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro
28. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium
29. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions
30. Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: The effect of viral titers on transduction efficiency
31. Improved methods of retroviral vector transduction and production for gene therapy
32. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or non mobilized with granulocyte colony-stimulating factor and/or stem cell factor
33. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
34. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells
35. Retrovirally-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after autologous transplantation
36. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model